InterCure: True International Cannabis Play
The cannabis market is ripe with investment opportunities whether in the U.S. or Canada, but very few good investments exist for companies focused outside of North America. After closing a SPAC deal, InterCure offers an impressive opportunity to invest in European growth via a small Israeli company. The stock is a solid buy considering the company doesn't come with an expensive price tag like most Canadian cannabis companies playing in European cannabis markets.
Read the full article on Seeking Alpha.
Disclosure: No position mentioned. Please review the disclaimer page for more details.
Update - July 25
The Israeli cannabis company could uplift to the Nasdaq as soon as this week. Investors should watch for a catalyst when this occurs with the stock only trading at $6.25 here after hitting a high of nearly $10.